How should enthesitis be managed in a breastfeeding mother, including safe non‑pharmacologic measures, compatible medications, disease‑modifying agents, and drugs to avoid?

Management of Enthesitis During Breastfeeding

Breastfeeding mothers with enthesitis should be treated with ibuprofen as the first-line NSAID, combined with paracetamol for multimodal analgesia, physical therapy, and rest—all of which are completely safe during lactation and require no interruption of nursing. 1

First-Line Pharmacologic Management

NSAIDs: Preferred Agents

• Ibuprofen is the safest and most extensively studied NSAID for breastfeeding mothers, with a relative infant dose less than 0.38% of the weight-adjusted maternal dose, well below the 10% safety threshold. 1
• Paracetamol (acetaminophen) should be combined with ibuprofen to provide multimodal analgesia, reducing total NSAID exposure while maintaining effective pain control. 2, 1
• Both medications can be taken immediately without interrupting nursing or discarding expressed milk—"pump and dump" is completely unnecessary. 1
• Use the lowest effective dose for the shortest duration needed, though no specific waiting period is required between doses and breastfeeding sessions. 2, 1

Alternative NSAIDs (If Ibuprofen Fails or Is Contraindicated)

• Diclofenac is the second-safest NSAID option after ibuprofen, with established compatibility and minimal milk transfer. 1, 3
• Naproxen is safe despite its longer half-life and is widely used postpartum in lactating patients. 1
• Ketorolac shows low breast-milk concentrations and has not been associated with adverse neonatal effects. 1
• Celecoxib and other COX-2 inhibitors have limited data during lactation and should be avoided when alternatives exist. 1

Non-Pharmacologic Management

Conservative Measures (First-Line Approach)

• Physical therapy, rest, and lifestyle modifications should be implemented before considering more aggressive interventions such as corticosteroid injections. 4
• Heat and cold therapy are safe alternatives for breastfeeding women and should be encouraged. 1
• These non-pharmacological approaches carry no risk to the nursing infant and should be maximized. 1

Advanced Pharmacologic Options

When NSAIDs Are Insufficient

• Methotrexate is the optimal DMARD for enthesitis-related arthritis, requiring a 3-month trial, though changing therapy may be appropriate after 6-8 weeks if minimal response is observed. 2
• Anti-TNF therapy (such as adalimumab, etanercept, or infliximab) is more effective than conventional DMARDs for enthesitis in the first year after diagnosis, with statistically significant improvements in active joint count, pain, and disease activity. 5
• IL-17 inhibitors (secukinumab, ixekizumab) and IL-23 inhibitors have shown significant efficacy in treating enthesitis in psoriatic arthritis and spondyloarthritis. 6
• JAK inhibitors and phosphodiesterase-4 inhibitors (apremilast) have demonstrated efficacy in enthesitis treatment. 6

Critical caveat: The evidence provided does not include specific lactation safety data for biologic DMARDs or targeted synthetic DMARDs. Clinical decision-making regarding these agents during breastfeeding requires consultation with rheumatology and consideration of disease severity versus theoretical infant exposure risks.

Corticosteroid Injections: Use With Extreme Caution

• Entheseal corticosteroid injections should be the last treatment option following NSAIDs, physiotherapy, rest, and lifestyle modifications. 4
• Diagnostic ultrasound is mandatory before injection to confirm the presence of inflammation and exclude tendon rupture. 4
• Perientheseal injections should be attempted before intraentheseal injections, and ultrasound guidance for needle placement is strongly encouraged. 4
• Avoid entheseal injections in high-risk patients, such as those with rupture at the enthesis. 4
• The literature on efficacy and tolerability of entheseal corticosteroid injection in spondyloarthritis and psoriatic arthritis is limited, and recommendations remain expert opinion. 4

Medications to Avoid

Contraindicated Analgesics

• Aspirin in analgesic doses should be avoided due to the risk of salicylate intoxication and neonatal bleeding. 1
• Opioids should not be used as default analgesics for breastfeeding mothers; they carry significantly higher risks of infant sedation, respiratory depression, and mortality compared with ibuprofen. 2, 1
• If opioids are absolutely necessary, morphine and dihydrocodeine are the preferred agents at the lowest effective dose for the shortest duration. 2

Special Monitoring Considerations

Infant Age-Related Precautions

• Extra caution is required for infants younger than 6 weeks of age (corrected for gestational age) due to immature hepatic and renal function, though ibuprofen and paracetamol remain safe options. 2, 1
• Sensitivity to medications follows the hierarchy: preterm infants > neonates > young infants. 2

When Opioids Are Used (If Unavoidable)

• Mothers should observe their infant for sedation, drowsiness, or behavioral changes; if these develop, withhold breastfeeding and seek medical advice immediately. 2
• Excessive maternal sedation should be monitored as an indicator of possible infant drug effects. 2

Clinical Algorithm for Enthesitis Management in Breastfeeding Mothers

1. Initiate ibuprofen (first-line) + paracetamol (multimodal analgesia) at the lowest effective doses. 1
2. Add physical therapy, rest, heat/cold therapy concurrently. 1, 4
3. If inadequate response after 2-4 weeks, switch to diclofenac or naproxen while continuing non-pharmacologic measures. 1, 3
4. If enthesitis persists despite NSAIDs and conservative measures, consider methotrexate (optimal trial = 3 months). 2
5. If minimal response after 6-8 weeks of methotrexate, escalate to anti-TNF therapy (most effective for enthesitis). 2, 5
6. Reserve corticosteroid injections as last resort, only after ultrasound confirmation of inflammation and exclusion of rupture, preferring perientheseal over intraentheseal approach. 4

Common Pitfalls to Avoid

• Do not advise "pump and dump" after taking ibuprofen or paracetamol—this is unnecessary and may lead to undesirable outcomes including cessation of breastfeeding. 1, 7
• Do not use opioids as routine analgesics when NSAIDs are effective and safe. 2, 1
• Do not perform entheseal injections without ultrasound guidance or without first confirming inflammation and excluding rupture. 4
• Do not delay DMARD therapy if NSAIDs fail—enthesitis is a key pathological process in spondyloarthritis and requires disease-modifying treatment. 8, 6